繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Allurion宣布发布新数据,证明患有肥胖的青少年体重减轻;在一项针对91名青少年的研究中,4个月时平均体重减轻13.1%,没有出现严重不良事件

2024-09-05 20:03

In a study of 91 adolescents, average weight loss was 13.1% at four months with no serious adverse events

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the publication of a study on the safety and effectiveness of the Allurion Program in adolescents.

In the study, 91 adolescents between 15 and 17 years-old with average body mass index (BMI) of 35.6 received the Allurion Balloon and the Allurion Program delivered by a multidisciplinary team, including a trained nutrition professional with adolescent experience. Average weight reduction was 13.1% four months after placement, with no serious adverse events or early device removals.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。